Vascular Closure Systems Inc. announces upcoming CE Mark of Fastseal® Bioabsorbable Vascular Access Closure System

6 October 2014

In 2015, commercial launch will involve one-third of the world markets.

Vascular Closure Systems Inc. announces upcoming CE Mark of Fastseal® Bioabsorbable Vascular Access Closure System

Vascular Closure Systems, Inc is pleased to announce the successful completion of an on-site inspection by  the independent Notified Body, and the upcoming submission of the Design Dossier as the final required step to receive CE Mark for the FastSeal® product line.  Receiving CE Mark will allow the Company to begin selling the FastSeal® system to approximately 1/3rd of the world markets.  “We would not have passed the Stage I and Stage II inspection, without the hard work and competent contributions of our world-class Quality, Regulatory and Clinical  consultants, both in Europe (Meditrial) and here in the US, as well as our engineers, technicians and our COO, John Bower” says Russ Houser, CEO.  The Company expects to receive CE Mark and begin commercialization, during Q4 2014.  

Vascular Closure Systems, Inc. will make a presentation on the successful clinical trials, as well as the many features and benefits of our FastSeal® Bioabsorbable Vascular Access Closure System, at the upcoming Italian Society of Invasive Cardiology SICI-GISE, 14 - 17 October. The Company will also have a booth at the congress. 

For more information, visit www.vclosure.com.

« Go back